Cargando…
IM-03 CD206 expression in peripheral blood-derived induced-microglia-like cells as a surrogate biomarker for the specific immune microenvironment of glioma
INTRODUCTION: As recent advancement of multimodal treatments including immune-check point inhibitors have not led to massive outcome improvement of glioma. Targeting the peculiar immune microenvironment of glioma is a promising approach to innovate a breakthrough treatment, however, there remains to...
Autores principales: | Hata, Nobuhiro, Tanaka, Shunya, Ohgidani, Masahiro, Inamine, Shogo, Sagata, Noriaki, Mukae, Nobutaka, Hatae, Ryusuke, Sangatsuda, Yuhei, Kato, Takahiro, Mizoguchi, Masahiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7699038/ http://dx.doi.org/10.1093/noajnl/vdaa143.031 |
Ejemplares similares
-
CD206 Expression in Induced Microglia-Like Cells From Peripheral Blood as a Surrogate Biomarker for the Specific Immune Microenvironment of Neurosurgical Diseases Including Glioma
por: Tanaka, Shunya, et al.
Publicado: (2021) -
ACT-02 Changes in Recurrence Pattern and Prognosis of Glioblastoma after Approval of Bevacizumab as First-line Application
por: Funakoshi, Yusuke, et al.
Publicado: (2020) -
Update on Chemotherapeutic Approaches and Management of Bevacizumab Usage for Glioblastoma
por: Funakoshi, Yusuke, et al.
Publicado: (2020) -
Pediatric Glioma: An Update of Diagnosis, Biology, and Treatment
por: Funakoshi, Yusuke, et al.
Publicado: (2021) -
Preliminary analysis of hippocampus synaptic apoptosis and microglial phagocytosis induced by severe restraint stress
por: Enomoto, Shingo, et al.
Publicado: (2022)